These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19497103)

  • 1. Factors related to compliance to anti-malarial drug combination: example of amodiaquine/sulphadoxine-pyrimethamine among children in rural Senegal.
    Souares A; Lalou R; Sene I; Sow D; Le Hesran JY
    Malar J; 2009 Jun; 8():118. PubMed ID: 19497103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-reported data: a major tool to assess compliance with anti-malarial combination therapy among children in Senegal.
    Souares A; Moulin P; Sarrassat S; Carlotti MP; Lalou R; Le Hesran JY
    Malar J; 2009 Nov; 8():257. PubMed ID: 19922609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence and effectiveness of drug combination in curative treatment among children suffering uncomplicated malaria in rural Senegal.
    Souares A; Lalou R; Sene I; Sow D; Le Hesran JY
    Trans R Soc Trop Med Hyg; 2008 Aug; 102(8):751-8. PubMed ID: 18603111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of chloroquine, amodiaquine, sulfadoxine-pyrimethamine, chloroquine-sulfadoxine-pyrimethamine combination, and amodiaquine-sulfadoxine-pyrimethamine combination in Central African children with noncomplicated malaria.
    Menard D; Madji N; Manirakiza A; Djalle D; Koula MR; Talarmin A
    Am J Trop Med Hyg; 2005 May; 72(5):581-5. PubMed ID: 15940847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Child age or weight: difficulties related to the prescription of the right dosage of antimalarial combinations to treat children in Senegal.
    Souares A; Lalou R; Senghor P; Le Hesran JY
    Trans R Soc Trop Med Hyg; 2010 Feb; 104(2):104-9. PubMed ID: 19716147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combined antimalarial therapy using artemisinin].
    Majori G
    Parassitologia; 2004 Jun; 46(1-2):85-7. PubMed ID: 15305693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amodiaquine dosage and tolerability for intermittent preventive treatment to prevent malaria in children.
    Cairns M; Cisse B; Sokhna C; Cames C; Simondon K; Ba EH; Trape JF; Gaye O; Greenwood BM; Milligan PJ
    Antimicrob Agents Chemother; 2010 Mar; 54(3):1265-74. PubMed ID: 20065053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artemisinin-based combinations versus amodiaquine plus sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Faladje, Mali.
    Kayentao K; Maiga H; Newman RD; McMorrow ML; Hoppe A; Yattara O; Traore H; Kone Y; Guirou EA; Saye R; Traore B; Djimde A; Doumbo OK
    Malar J; 2009 Jan; 8():5. PubMed ID: 19128455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria: revisiting molecular markers in an area of emerging AQ and SP resistance in Mali.
    Tekete M; Djimde AA; Beavogui AH; Maiga H; Sagara I; Fofana B; Ouologuem D; Dama S; Kone A; Dembele D; Wele M; Dicko A; Doumbo OK
    Malar J; 2009 Feb; 8():34. PubMed ID: 19245687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of amodiaquine and artesunate on sulphadoxine-pyrimethamine pharmacokinetic parameters in children under five in Mali.
    Tekete MM; Toure S; Fredericks A; Beavogui AH; Sangare CP; Evans A; Smith P; Maiga H; Traore ZI; Doumbo OK; Barnes KI; Djimde AA
    Malar J; 2011 Sep; 10():275. PubMed ID: 21936885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of chloroquine, amodiaquine, sulphadoxine-pyrimethamine and combination therapy with artesunate in Mozambican children with non-complicated malaria.
    Abacassamo F; Enosse S; Aponte JJ; Gómez-Olivé FX; Quintó L; Mabunda S; Barreto A; Magnussen P; Rønn AM; Thompson R; Alonso PL
    Trop Med Int Health; 2004 Feb; 9(2):200-8. PubMed ID: 15040556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of uncomplicated malaria in children under 13 years of age at a district hospital in Senegal: from official guidelines to usual practices.
    Sarrassat S; Lalou R; Cissé M; Le Hesran JY
    Malar J; 2011 Sep; 10():285. PubMed ID: 21958422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved efficacy with amodiaquine instead of chloroquine in sulfadoxine/pyrimethamine combination treatment of falciparum malaria in Uganda: experience with fixed-dose formulation.
    Obua C; Gustafsson LL; Aguttu C; Anokbonggo WW; Ogwal-Okeng JW; Chiria J; Hellgren U
    Acta Trop; 2006 Nov; 100(1-2):142-50. PubMed ID: 17113554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artesunate + amodiaquine and artesunate + sulphadoxine-pyrimethamine for treatment of uncomplicated malaria in Democratic Republic of Congo: a clinical trial with determination of sulphadoxine and pyrimethamine-resistant haplotypes.
    Swarthout TD; van den Broek IV; Kayembe G; Montgomery J; Pota H; Roper C
    Trop Med Int Health; 2006 Oct; 11(10):1503-11. PubMed ID: 17002724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amodiaquine alone, amodiaquine+sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial.
    Mutabingwa TK; Anthony D; Heller A; Hallett R; Ahmed J; Drakeley C; Greenwood BM; Whitty CJ
    Lancet; 2005 Apr 23-29; 365(9469):1474-80. PubMed ID: 15850631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to intermittent preventive treatment for malaria in Papua New Guinean infants: A pharmacological study alongside the randomized controlled trial.
    Sottas O; Guidi M; Thieffry B; Schneider M; Décosterd L; Mueller I; Genton B; Csajka C; Senn N
    PLoS One; 2019; 14(2):e0210789. PubMed ID: 30726224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
    Marfurt J; Müeller I; Sie A; Maku P; Goroti M; Reeder JC; Beck HP; Genton B
    Am J Trop Med Hyg; 2007 Nov; 77(5):947-54. PubMed ID: 17984359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic efficacy of sulfadoxine-pyrimethamine, amodiaquine and the sulfadoxine-pyrimethamine-amodiaquine combination against uncomplicated Plasmodium falciparum malaria in young children in Cameroon.
    Basco LK; Same-Ekobo A; Ngane VF; Ndounga M; Metoh T; Ringwald P; Soula G
    Bull World Health Organ; 2002; 80(7):538-45. PubMed ID: 12163917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the parasitologic efficacy of amodiaquine and sulfadoxine-pyrimethamine in the treatment of Plasmodium falciparum malaria in the Bungoma District of western Kenya.
    Vreugdenhil CJ; Scheper FY; Hoogstraatte SR; Smolders M; Gikunda S; Cobelens FG; Kager PA
    Am J Trop Med Hyg; 2004 Nov; 71(5):537-41. PubMed ID: 15569779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized trial of piperaquine with sulfadoxine-pyrimethamine or dihydroartemisinin for malaria intermittent preventive treatment in children.
    Cisse B; Cairns M; Faye E; NDiaye O; Faye B; Cames C; Cheng Y; NDiaye M; Lô AC; Simondon K; Trape JF; Faye O; NDiaye JL; Gaye O; Greenwood B; Milligan P
    PLoS One; 2009 Sep; 4(9):e7164. PubMed ID: 19784374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.